Found: 13
Select item for more details and to access through your institution.
Clinical Characteristics and Microorganisms Isolated in Community-Acquired Pneumonia in the COVID-19 Period.
- Published in:
- Canadian Journal of Infectious Diseases & Medical Microbiology, 2024, v. 2024, p. 1, doi. 10.1155/2024/5948747
- By:
- Publication type:
- Article
Use of Matrix-Assisted Laser Desorption Ionization Time-of-Flight Mass Spectrometry Analysis of Serum Peptidome to Classify and Predict Coronavirus Disease 2019 Severity.
- Published in:
- Open Forum Infectious Diseases, 2021, v. 8, n. 6, p. 1, doi. 10.1093/ofid/ofab222
- By:
- Publication type:
- Article
Monitoring the antimicrobial susceptibility of Gramnegative organisms involved in intraabdominal and urinary tract infections recovered during the SMART study (Spain, 2016 and 2017).
- Published in:
- Revista Española de Quimioterapia, 2019, v. 32, n. 2, p. 145
- By:
- Publication type:
- Article
Predictive Immunological, Virological, and Routine Laboratory Markers for Critical COVID-19 on Admission.
- Published in:
- Canadian Journal of Infectious Diseases & Medical Microbiology, 2021, v. 2021, p. 1, doi. 10.1155/2021/9965850
- By:
- Publication type:
- Article
A Genomic Snapshot of the SARS-CoV-2 Pandemic in the Balearic Islands.
- Published in:
- Frontiers in Microbiology, 2022, v. 12, p. 1, doi. 10.3389/fmicb.2021.803827
- By:
- Publication type:
- Article
Increased mRNA Levels of ADAM17 , IFITM3 , and IFNE in Peripheral Blood Cells Are Present in Patients with Obesity and May Predict Severe COVID-19 Evolution.
- Published in:
- Biomedicines, 2022, v. 10, n. 8, p. N.PAG, doi. 10.3390/biomedicines10082007
- By:
- Publication type:
- Article
Activity of cefiderocol, imipenem/relebactam, cefepime/taniborbactam and cefepime/zidebactam against ceftolozane/tazobactam- and ceftazidime/avibactam-resistant Pseudomonas aeruginosa.
- Published in:
- 2022
- By:
- Publication type:
- journal article
In vivo translational assessment of the GES genotype on the killing profile of ceftazidime, ceftazidime/avibactam and meropenem against Pseudomonas aeruginosa.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Molecular and biochemical insights into the in vivo evolution of AmpC-mediated resistance to ceftolozane/tazobactam during treatment of an MDR Pseudomonas aeruginosa infection.
- Published in:
- 2020
- By:
- Publication type:
- journal article
In vitro dynamics and mechanisms of resistance development to imipenem and imipenem/relebactam in Pseudomonas aeruginosa.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Mechanisms leading to in vivo ceftolozane/tazobactam resistance development during the treatment of infections caused by MDR Pseudomonas aeruginosa.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Neonatal SARS-CoV-2 immunoglobulin G antibodies at delivery and their impact on COVID-19.
- Published in:
- European Journal of Clinical Microbiology & Infectious Diseases, 2024, v. 43, n. 4, p. 693, doi. 10.1007/s10096-024-04773-3
- By:
- Publication type:
- Article
Ceftolozane/tazobactam for the treatment of multidrug resistant Pseudomonas aeruginosa: experience from the Balearic Islands.
- Published in:
- European Journal of Clinical Microbiology & Infectious Diseases, 2018, v. 37, n. 11, p. 2191, doi. 10.1007/s10096-018-3361-0
- By:
- Publication type:
- Article